PIRAMAL PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.49 INR | -3.81% |
|
-14.74% | -26.18% |
| Jan. 29 | Piramal Pharma Limited, Q3 2025 Earnings Call, Jan 29, 2025 | |
| Jan. 29 | Piramal Pharma's Fiscal Q3 Consolidated Profit Falls | MT |
Chart calendar Piramal Pharma Limited
b41238cfda8c628a818c3e2399e26.3F8vBsFWed0YSiTefXyH1k6n3QDAtVcx0rfKE1bfxpU.khVGaewPGLpqBxGoTTrDpg2SuVGh_xRFltyNdxeshKeWEH1LiGMat14JEA~b996659e7140b51d01b12879f800e17c
Upcoming events on Piramal Pharma Limited
Past events on Piramal Pharma Limited
| 2025-02-10 | Nuvama India Investor Conference |
| 2025-02-05 | Investor Conference By ICICI Securities |
| 2025-01-29 07:00 am | Q3 2025 Earnings Call |
| 2025-01-28 10:27 am | Q3 2025 Earnings Release |
| 2024-11-20 | Kotak Midcap Conference |
| 2024-11-11 | Avendus Spark Investor Conference |
| 2024-10-24 07:30 am | Q2 2025 Earnings Call |
| 2024-10-23 10:37 am | Q2 2025 Earnings Release |
| 2024-09-24 06:30 am | Investor Meeting |
| 2024-09-16 | Jefferies India Forum |
| 2024-09-02 | Ashwamedh Elara India Dialogue Conference |
| 2024-08-21 | Systematix Group CDMO Pharma Conference |
| 2024-08-20 | Motilal Oswal Global Investor Conference |
| 2024-08-12 | Emkay Confluence India Conference |
| 2024-07-26 07:30 am | Q1 2025 Earnings Call |
| 2024-07-26 05:30 am | Annual General Meeting |
| 2024-07-26 03:11 am | Q1 2025 Earnings Release |
| 2024-06-17 | Nuvama Speciality Chemicals & Healthcare Day |
| 2024-06-09 | Investor Meeting - Goldman Sachs India Securities Ltd |
| 2024-06-06 | Titans of Tomorrow Conference |
Past dividends on Piramal Pharma Limited
| 2024-07-11 | Annual 0.11 INR |
Annual results
| Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 0,00 | 70 816 69 704 1.59% | 81 712 81 131 0.72% | 93 012 | 106 782 | 122 747 |
|
EBITDA Million INR | Released Forecast Spread | 0,00 | 6 282 5 726 9.71% | 11 963 11 167 7.12% | 14 799 | 19 031 | 23 302 |
|
EBIT Million INR | Released Forecast Spread | 0,00 | -485 -1 193 59.38% | 4 557 3 846 18.5% | 7 097 | 10 938 | 14 576 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 0,00 | -1 202 -1 099 -9.38% | 1 793 1 335 34.3% | 4 470 | 8 676 | 12 946 |
|
Net income Million INR | Released Forecast Spread | 3 760 | -1 865 -1 899 1.84% | 178 1 178 -84.87% | 1 282 | 5 463 | 8 607 |
|
EPS INR | Released Forecast Spread | 3,19 | -1,57 -1,00 -57% | 0,14 0,75 -81.33% | 0,97 | 4,16 | 6,51 |
| Announcement Date | 24/05/22 | 24/05/23 | 10/05/24 | - |
Quarterly results
| Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 17 160 17 922 -4.25% | 21 636 21 095 2.56% | 17 489 17 125 2.13% | 19 114 19 257 -0.75% | 19 586 20 066 -2.39% | 25 524 24 785 2.98% | 19 511 19 351 0.83% | 21 695 | 21 252 | 27 569 | |
|
EBITDA Million INR | Released Forecast Spread | 873 2 289 -61.84% | 3 513 2 700 30.12% | 1 323 1 398 -5.35% | 2 656 2 232 19.01% | 2 684 3 011 -10.88% | 5 299 4 498 17.83% | 2 045 1 589 28.69% | 2 895 | 2 614 | 5 557 | |
|
EBIT Million INR | Released Forecast Spread | -771 665 -215.94% | 1 669 184 806.85% | -413 -516 19.98% | 811 498 62.91% | 821 1 307 -37.22% | 3 338 3 099 7.71% | 199 -192 203.85% | 750 | 381 | 3 739 | |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | -736 430 -271.26% | 949 48,0 1876.88% | -1 071 -1 116 4.02% | 396 348 13.68% | 194 1 067 -81.86% | 2 275 2 761 -17.61% | 380 | 161 | 3 953 | ||
|
Net income Million INR | Released Forecast Spread | -373 | -902 400 -325.45% | 501 157 219.17% | -986 -1 116 11.67% | 50,2 24,5 104.9% | 101 832 -87.85% | 1 013 1 970 -48.59% | -886 -749 -18.29% | 318 | 197 | 1 944 |
|
EPS INR | Released Forecast Spread | -0,31 | 0,04 | |||||||||
| Announcement Date | 09/11/22 | 08/02/23 | 24/05/23 | 03/08/23 | 27/10/23 | 30/01/24 | 10/05/24 | 26/07/24 | - | - | - |
| 2025-02-12 | RECORDATI: Q4 2024 Earnings Release |
| 2025-02-12 | TOWA PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release |
| 2025-02-12 | IPCA LABORATORIES LIMITED: Q3 2025 Earnings Release |
| 2025-02-12 | CAMURUS AB: Q4 2024 Earnings Release |
| 2025-02-13 01:00 am | IPSEN: Q4 2024 Earnings Release |
| 2025-02-13 07:30 am | ORGANON & CO.: Q4 2024 Earnings Release |
| 2025-02-13 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 2025-02-13 | SAWAI GROUP HOLDINGS CO., LTD.: Q3 2024 Earnings Release |
| 2025-02-13 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release |
| 2025-02-17 | GC BIOPHARMA CORP.: Q4 2024 Earnings Release (Projected) |
Past sector events for Piramal Pharma Limited
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PPLPHARMA Stock
- Calendar Piramal Pharma Limited